Cargando…
Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
Autores principales: | van Donge, Tamara, Brizzi, Francesco, Caruso, Antonello, Fueth, Matthias, Steiert, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108726/ https://www.ncbi.nlm.nih.gov/pubmed/37040126 http://dx.doi.org/10.1167/tvst.12.4.9 |
Ejemplares similares
-
Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin
por: Hauri, Simon, et al.
Publicado: (2020) -
Does the Fc Region Have a Role in the Ocular Half-life After Intravitreal Injection?
por: Caruso, Antonello, et al.
Publicado: (2020) -
Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits
por: Kim, Hyeong Min, et al.
Publicado: (2020) -
Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
por: Yılmaz, Turgut, et al.
Publicado: (2017) -
Erratum in: Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits
Publicado: (2023)